Quick-Med Technologies (QMT) specializes in developing innovative antimicrobial technologies that prioritize sustainability and safety. Their flagship technologies, NIMBUS and Stay Fresh, are designed to combat infection while minimizing environmental impact. NIMBUS is a unique wound dressing that utilizes a non-leaching antimicrobial agent, ensuring that bacteria cannot develop resistance, making it the only product of its kind approved by the FDA. This technology is intrinsically bound to the dressing substrate, maintaining its efficacy even after rinsing. On the other hand, Stay Fresh technology employs hydrogen peroxide, which is preserved in a dry state within various products, including textiles and coatings. This approach not only disrupts bacterial cell walls but also results in non-toxic degradation products, making it safe for human use and environmentally friendly.

In addition to their core technologies, QMT is committed to ongoing research and development in antimicrobial materials, ocular therapies, and superabsorbent products. Their efforts are supported by significant government grants, enabling them to explore new applications and enhance existing technologies. The company also focuses on creating sustainable feminine hygiene products that are both effective and environmentally responsible. By engaging with clients and incorporating feedback, QMT continuously optimizes its offerings to meet diverse market needs while addressing the growing concern of antimicrobial resistance.

United States

The next generation of wound care products won't only cover your wounds, they'll actively kill bacteria and help your body heal itself.

We research & develop long-lasting antimicrobial wound care products with no bacterial resistance. Recently granted FDA cleared and patent approval.

Quick-Med Technologies

Company Details